Modular Medical (Modular Medical) Beneish M-Score : 0.00 (As of Jun. 10, 2024)

View and export this data going back to . Start your Free Trial

What is Modular Medical Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Modular Medical's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of Modular Medical was 0.00. The lowest was 0.00. And the median was 0.00.

Modular Medical Beneish M-Score Historical Data

The historical data trend for Modular Medical's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modular Medical Beneish M-Score Chart

Modular Medical Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Beneish M-Score

Get a 7-Day Free Trial

Modular Medical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Beneish M-Score	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Modular Medical's Beneish M-Score

For the Medical Devices subindustry, Modular Medical's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Modular Medical's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Modular Medical's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Modular Medical's Beneish M-Score falls into.

Modular Medical Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Modular Medical for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 *

0.528 *

0.404 *

0.892 *

0.115 *

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 *

4.679 *

0.327 *

This Year (Dec23) TTM:

Last Year (Dec22) TTM:

Total Receivables was $0.00 Mil.
Revenue was 0 + 0 + 0 + 0 = $0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = $0.00 Mil.
Total Current Assets was $2.34 Mil.
Total Assets was $6.20 Mil.
Property, Plant and Equipment(Net PPE) was $3.86 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.34 Mil.
Selling, General, & Admin. Expense(SGA) was $5.32 Mil.
Total Current Liabilities was $1.44 Mil.
Long-Term Debt & Capital Lease Obligation was $0.92 Mil.
Net Income was -5.269 + -4.183 + -3.737 + -3.571 = $-16.76 Mil.
Non Operating Income was 0 + 0.009 + 0.014 + 0.001 = $0.02 Mil.
Cash Flow from Operations was -3.965 + -3.277 + -3.207 + -2.828 = $-13.28 Mil.

Total Receivables was $0.00 Mil.
Revenue was 0 + 0 + 0 + 0 = $0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = $0.00 Mil.
Total Current Assets was $7.97 Mil.
Total Assets was $8.74 Mil.
Property, Plant and Equipment(Net PPE) was $0.77 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.07 Mil.
Selling, General, & Admin. Expense(SGA) was $5.54 Mil.
Total Current Liabilities was $0.72 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(0 / 0)	/	(0 / 0)
	=		/
	=

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(0 / 0)	/	(0 / 0)
	=		/
	=

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (2.342 + 3.857) / 6.199)	/	(1 - (7.971 + 0.768) / 8.739)
	=	0	/	0
	=

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	0	/	0
	=

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(0.072 / (0.072 + 0.768))	/	(0.342 / (0.342 + 3.857))
	=	0.085714	/	0.081448
	=

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(5.322 / 0)	/	(5.543 / 0)
	=		/
	=

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((0.915 + 1.439) / 6.199)	/	((0 + 0.715) / 8.739)
	=	0.379739	/	0.081817
	=

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(-16.76 - 0.024	-	-13.277)	/	6.199
	=	-0.565736

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Modular Medical Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Modular Medical's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Modular Medical (Modular Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Modular Medical Inc (NAS:MODD) » Definitions » Beneish M-Score

Comparable Companies

Traded in Other Exchanges

N/A

Address

10470 Thornmint Road, San Diego, CA, USA, 92127

Website

https://www.modular-medical.com

Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of an insulin pump using modernized technology to increase pump adoption in the diabetes marketplace. The company's product's seeks to serve both the type 1 and the rapidly growing especially in terms of device adoption, type 2 diabetes markets.

Executives

Philip Brent Sheibley	director	C/O MODULAR MEDICAL, INC., 16772 W. BERNARDO DRIVE, SAN DIEGO CA 92127
Manchester Management Co Llc	10 percent owner	3 WEST HILL PLACE, BOSTON MA 02110
Jeb Partners, L.p.	other: Director by Deputization	MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, BOSTON MA 02114
Kevin Schmid	officer: Chief Operating Officer	8 EAGLES NEST LANE, BEDFORD MA 01921
Paul Diperna	director, 10 percent owner, officer: See Remarks	16772 W BERNARDO DRIVE, RANCHO BERNARDO CA 92127
Carmen B Volkart	director	C/O MODULAR MEDICAL, INC., 16772 WEST BERNARDO DRIVE, SAN DIEGO CA 92127
Duane M Desisto	director	INSULET CORPORATION, 9 OAK PARK DRIVE, BEDFORD MA 01730
Ellen O'connor Vos	director	C/O NTELOS HOLDINGS CORP., 1154 SHENANDOAH VILLAGE DRIVE, WAYNESBORO VA 22980
Steven G Felsher	director	C/O SITO MOBILE, LTD.,, 100 TOWN SQUARE PLACE, STE 204, JERSEY CITY NJ 07310
Morgan C. Frank	10 percent owner	2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Paul Diperna Irrevocable Trust	other: See Footnote(1)	16772 WEST BERNARDO DRIVE, SAN DIEGO CA 92127
Stephen Edward Daly	officer: Chief Commercial Officer	2090 DIPINTO ROAD, HENDERSON NV 89052
William J Febbo	director	600 CALIFORNIA ST., 9TH FLOOR, SAN FRANCISCO CA 94108
Liam Burns	director	C/O MODULAR MEDICAL, INC., 800 W. VALLEY PARKWAY, SUITE 203, ESCONDIDO CA 92025
James E Besser	10 percent owner	3 WEST HILL PLACE, BOSTON MA 02114